胃潰瘍の世界市場レポート 2024年

胃潰瘍市場規模は、今後数年間で力強い成長が見込まれます。2028年にはCAGR5.6％で53億4,000万米ドルに成長します。予測期間の成長は、診断技術の向上、不健康な食習慣の採用、プロトンポンプ阻害薬（PPI）などの治療オプションの進歩、疾病負担の増加に寄与する高齢化、新興市場における医療インフラの拡大などに起因すると考えられます。この期間の主要動向としては、有効性を高めるための併用療法へのシフト、低侵襲治療への嗜好の高まり、疾患管理におけるデジタルヘルスソリューションの統合、市販薬（OTC）潰瘍治療の需要増加、潰瘍治療における個別化医療アプローチの拡大などが挙げられます。

胃潰瘍市場の成長を牽引しているのは、高齢者人口の増加です。この層は一般的に65歳以上の高齢者であり、加齢に伴う特有の健康課題を抱えています。医療の進歩による平均寿命の延長や出生率の低下が、世界の高齢者人口の増加に寄与しています。胃潰瘍は、非ステロイド性抗炎症薬（NSAIDs）の使用頻度が高く、粘膜保護機能が低下しているため、合併症のリスクが高く、特に高齢者に多くみられます。世界保健機関（WHO）によると、60歳以上の世界人口は2020年の10億人から2030年には14億人、2050年には21億人と大幅に増加すると予測されています。さらに、80歳以上の人口は3倍に増え、2050年には4億2,600万人に達すると予想されています。その結果、高齢者人口の拡大が胃潰瘍市場の成長に拍車をかけています。

胃潰瘍市場の主要参入企業は、顧客により良いサービスを提供するため、カプセルのジェネリック医薬品を含む革新的な医薬品の開発に注力しています。ジェネリックカプセルには、胃潰瘍の治療や管理に使用されるプロトンポンプ阻害薬（PPI）、H2受容体拮抗薬、その他の潰瘍治療などの有効成分が含まれています。例えば、2021年9月、インドに本社を置く製薬会社Dr. Reddy's Laboratoriesは、米国市場でリブラックスのジェネリック医薬品（クロルジアゼポキシド塩酸塩・臭化クリジニウムカプセル）を発売しました。今回の発売により、患者は胃潰瘍と関連する消化器疾患の治療において、先発医薬品であるリブラックスよりも費用対効果の高い選択肢を得ることができます。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 マクロ経済シナリオ

• 高インフレが市場に与える影響
• ウクライナ・ロシア戦争が市場に与える影響
• COVID-19による市場への影響

第5章 世界の市場規模と成長

• 世界の胃潰瘍市場：促進要因と抑制要因
  • 市場促進要因
  • 市場抑制要因
• 世界の胃潰瘍市場の実績：規模と成長、2018～2023年
• 世界の胃潰瘍市場の予測：規模と成長、2023～2028年、2033年

第6章 市場セグメンテーション

• 世界の胃潰瘍市場：薬剤クラス別、実績と予測、2018～2023年、2023～2028年、2033年
• プロトンポンプ阻害剤（PPI）
• H2拮抗薬
• 制酸剤
• 抗生物質
• 細胞保護剤
• その他
• 世界の胃潰瘍市場：診断別、実績と予測、2018～2023年、2023～2028年、2033年
• 便試験
• 内視鏡試験
• 画像試験
• コンピュータ断層撮影（CT）スキャン
• X線
• 血液試験
• その他
• 世界の胃潰瘍市場：投与経路別、実績と予測、2018～2023年、2023～2028年、2033年
• 経口
• 非経口
• その他
• 世界の胃潰瘍市場：流通チャネル別、実績と予測、2018～2023年、2023～2028年、2033年
• 病院薬局
• 小売薬局
• オンライン薬局
• その他
• 世界の胃潰瘍市場：エンドユーザー別、実績と予測、2018～2023年、2023～2028年、2033年
• 病院
• 専門クリニック
• 在宅医療
• その他

第7章 地域別・国別分析

• 世界の胃潰瘍市場：地域別、実績と予測、2018～2023年、2023～2028年、2033年
• 世界の胃潰瘍市場：国別、実績と予測、2018～2023年、2023～2028年、2033年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 胃潰瘍市場：競合情勢
• 胃潰瘍市場：企業プロファイル
  • Pfizer Inc.
  • Merck & Co Inc.
  • AbbVie Inc.
  • Sanofi S.A.
  • AstraZeneca plc

第31章 その他の大手企業と革新的企業

• Abbott Laboratories
• Novartis AG
• GlaxoSmithKline plc
• Takeda Pharmaceutical Co. Ltd
• Amgen Inc.
• Boehringer Ingelheim
• Viatris Inc.
• Daiichi Sankyo Company Limited
• Eisai Co. Ltd
• Cadila Pharmaceuticals
• Dr. Reddy's Laboratories Ltd.
• Hikma Pharmaceuticals PLC
• Lupin Limited
• Yuhan Corporation
• Daewoong Pharmaceutical Co. Ltd

第32章 競合ベンチマーキング

第33章 競合ダッシュボード

第34章 主要な合併と買収

第35章 将来の展望と潜在的な分析

第36章 付録

Gastric ulcers, also known as peptic ulcers, are open sores on the stomach's inner lining caused by the corrosive action of stomach acid. They often result in burning stomach pain, indigestion, and discomfort. These ulcers typically arise from an imbalance between stomach acid, the enzyme pepsin, and the protective mucosal barrier lining the stomach and duodenum.

The primary drug classes used to treat gastric ulcers include proton pump inhibitors (PPIs), H2 antagonists, antacids, antibiotics, cytoprotective agents, and others. Proton pump inhibitors are medications that reduce stomach acid production by inhibiting the proton pump enzyme in gastric cells. Gastric ulcers can be diagnosed through stool tests, endoscopies, imaging tests, computed tomography (CT) scans, X-rays, blood tests, and other methods. Treatment routes include oral and parenteral administration, among others. Distribution channels primarily consist of hospital pharmacies, retail pharmacies, and online pharmacies, and the treatments are utilized by various end-users such as hospitals, specialty clinics, and homecare settings.

The gastric ulcers market research report is one of a series of new reports from The Business Research Company that provides gastric ulcers market statistics, including gastric ulcers industry global market size, regional shares, competitors with a gastric ulcers market share, detailed gastric ulcers market segments, market trends and opportunities, and any further data you may need to thrive in the gastric ulcers industry. This gastric ulcers market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The gastric ulcers market size has grown strongly in recent years. It will grow from $4.07 billion in 2023 to $4.29 billion in 2024 at a compound annual growth rate (CAGR) of 5.3%. The growth during the historical period can be attributed to several factors, the rising prevalence of Helicobacter pylori infections, the increasing use of nonsteroidal anti-inflammatory drugs (NSAIDs), the global growth of the geriatric population, rising awareness campaigns for gastric ulcer prevention, and the increasing incidence of stress-related disorders.

The gastric ulcers market size is expected to see strong growth in the next few years. It will grow to $5.34 billion in 2028 at a compound annual growth rate (CAGR) of 5.6%. Growth in the forecast period can be attributed to improvements in diagnostic techniques, the adoption of unhealthy dietary habits, advancements in treatment options such as proton pump inhibitors (PPIs), an aging population contributing to a higher disease burden, and the expansion of healthcare infrastructure in emerging markets. Major trends during this period include a shift towards combination therapies for enhanced efficacy, a growing preference for minimally invasive treatment procedures, the integration of digital health solutions in disease management, rising demand for over-the-counter (OTC) ulcer medications, and the expansion of personalized medicine approaches in ulcer treatment.

The growth of the gastric ulcers market is being driven by the increasing geriatric population. This demographic, typically individuals aged 65 and older, experiences specific health challenges related to aging. Advances in healthcare, resulting in longer life expectancy and declining birth rates, are contributing to the rise in the geriatric population globally. Gastric ulcers are particularly prevalent among the elderly due to higher use of NSAIDs and reduced mucosal protection, leading to greater risk of complications. According to the World Health Organization, the global population aged 60 and over is projected to grow significantly, from 1 billion in 2020 to 1.4 billion by 2030, and to 2.1 billion by 2050. Additionally, the number of individuals aged 80 or older is expected to triple, reaching 426 million by 2050. Consequently, the expanding geriatric population is fueling the growth of the gastric ulcers market.

Key players in the gastric ulcer market are focusing on developing innovative drugs, including generic versions of capsules, to better serve customers. Generic capsules contain active ingredients such as proton pump inhibitors (PPIs), H2-receptor antagonists, or other ulcer-healing agents used to treat or manage gastric ulcers. For example, in September 2021, Dr. Reddy's Laboratories, an India-based pharmaceutical company, launched a generic version of Librax (Chlordiazepoxide Hydrochloride and Clidinium Bromide capsules) in the US market. This launch provides patients with a more cost-effective option for treating stomach ulcers and related gastrointestinal conditions than the branded drug Librax.

In May 2022, Dr. Reddy's Laboratories partnered with HK Inno.N. Corporation to supply and commercialize Tegoprazan, a novel molecule for gastrointestinal diseases, in India and six key emerging markets. Under this partnership, HK Inno.N. will manufacture and supply Tegoprazan, while Dr. Reddy's will oversee local clinical development, registration, marketing, and sales in the licensed territories. HK Inno.N. Corporation is a South Korea-based pharmaceutical company specializing in drugs for gastric ulcers.

Major companies operating in the gastric ulcers market are Pfizer Inc., Merck & Co Inc., AbbVie Inc., Sanofi S.A., AstraZeneca plc, Abbott Laboratories, Novartis AG, GlaxoSmithKline plc, Takeda Pharmaceutical Co. Ltd, Amgen Inc., Boehringer Ingelheim, Viatris Inc., Daiichi Sankyo Company Limited, Eisai Co. Ltd, Cadila Pharmaceuticals, Dr. Reddy's Laboratories Ltd., Hikma Pharmaceuticals PLC, Lupin Limited, Yuhan Corporation, Daewoong Pharmaceutical Co. Ltd, Cadila Healthcare Ltd, Novitium Pharma LLC

North America was the largest region in the gastric ulcers market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the gastric ulcers market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the gastric ulcers market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The gastric ulcers market consists of revenues earned by entities through barium swallow, H. pylori testing, and biopsy. The market value includes the value of related goods sold by the service provider or included within the service offering. The gastric ulcers market also includes sales of amoxicillin, clarithromycin, metronidazole, omeprazole, and lansoprazole. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Gastric Ulcers Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on gastric ulcers market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
• Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
• Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
• Measure the impact of high global inflation on market growth.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for gastric ulcers ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The gastric ulcers market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of COVID-19 on supply chains and consumption patterns.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Drug Class: Proton Pump Inhibitors (PPI); H2 Antagonists; Antacids; Antibiotics; Cytoprotective Agents; Other Drug Classes
• 2) By Diagnosis: Stool Test; Endoscopy; Imaging Tests; Computed Tomography (CT) Scan; X-ray; Blood Tests; Other Diagnosis
• 3) By Route Of Administration: Oral; Parenteral; Other Route Of Administrations
• 4) By Distribution Channel: Hospital Pharmacy; Retail Pharmacy; Online Pharmacy; Other Distribution Channels
• 5) By End-Users: Hospitals; Specialty Clinics; Homecare; Other End Users
• Companies Mentioned: Pfizer Inc.; Merck & Co Inc.; AbbVie Inc.; Sanofi S.A.; AstraZeneca plc
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Gastric Ulcers Market Characteristics

3. Gastric Ulcers Market Trends And Strategies

4. Gastric Ulcers Market - Macro Economic Scenario

• 4.1. Impact Of High Inflation On The Market
• 4.2. Ukraine-Russia War Impact On The Market
• 4.3. COVID-19 Impact On The Market

5. Global Gastric Ulcers Market Size and Growth

• 5.1. Global Gastric Ulcers Market Drivers and Restraints
  • 5.1.1. Drivers Of The Market
  • 5.1.2. Restraints Of The Market
• 5.2. Global Gastric Ulcers Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
• 5.3. Global Gastric Ulcers Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Gastric Ulcers Market Segmentation

• 6.1. Global Gastric Ulcers Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Proton Pump Inhibitors (PPI)
• H2 Antagonists
• Antacids
• Antibiotics
• Cytoprotective Agents
• Other Drug Classes
• 6.2. Global Gastric Ulcers Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Stool Test
• Endoscopy
• Imaging Tests
• Computed Tomography (CT ) Scan
• X-ray
• Blood Tests
• Other Diagnosis
• 6.3. Global Gastric Ulcers Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Oral
• Parenteral
• Other Route Of Administrations
• 6.4. Global Gastric Ulcers Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Hospital Pharmacy
• Retail Pharmacy
• Online Pharmacy
• Other Distribution Channels
• 6.5. Global Gastric Ulcers Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Hospitals
• Specialty Clinics
• Homecare
• Other End Users

7. Gastric Ulcers Market Regional And Country Analysis

• 7.1. Global Gastric Ulcers Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 7.2. Global Gastric Ulcers Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Gastric Ulcers Market

• 8.1. Asia-Pacific Gastric Ulcers Market Overview
• Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Gastric Ulcers Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.3. Asia-Pacific Gastric Ulcers Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.4. Asia-Pacific Gastric Ulcers Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Gastric Ulcers Market

• 9.1. China Gastric Ulcers Market Overview
• 9.2. China Gastric Ulcers Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.3. China Gastric Ulcers Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.4. China Gastric Ulcers Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Gastric Ulcers Market

• 10.1. India Gastric Ulcers Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.2. India Gastric Ulcers Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.3. India Gastric Ulcers Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Gastric Ulcers Market

• 11.1. Japan Gastric Ulcers Market Overview
• 11.2. Japan Gastric Ulcers Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.3. Japan Gastric Ulcers Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.4. Japan Gastric Ulcers Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Gastric Ulcers Market

• 12.1. Australia Gastric Ulcers Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.2. Australia Gastric Ulcers Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.3. Australia Gastric Ulcers Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Gastric Ulcers Market

• 13.1. Indonesia Gastric Ulcers Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.2. Indonesia Gastric Ulcers Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.3. Indonesia Gastric Ulcers Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Gastric Ulcers Market

• 14.1. South Korea Gastric Ulcers Market Overview
• 14.2. South Korea Gastric Ulcers Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.3. South Korea Gastric Ulcers Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.4. South Korea Gastric Ulcers Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Gastric Ulcers Market

• 15.1. Western Europe Gastric Ulcers Market Overview
• 15.2. Western Europe Gastric Ulcers Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.3. Western Europe Gastric Ulcers Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.4. Western Europe Gastric Ulcers Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Gastric Ulcers Market

• 16.1. UK Gastric Ulcers Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.2. UK Gastric Ulcers Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.3. UK Gastric Ulcers Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Gastric Ulcers Market

• 17.1. Germany Gastric Ulcers Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.2. Germany Gastric Ulcers Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.3. Germany Gastric Ulcers Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Gastric Ulcers Market

• 18.1. France Gastric Ulcers Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.2. France Gastric Ulcers Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.3. France Gastric Ulcers Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Gastric Ulcers Market

• 19.1. Italy Gastric Ulcers Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.2. Italy Gastric Ulcers Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.3. Italy Gastric Ulcers Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Gastric Ulcers Market

• 20.1. Spain Gastric Ulcers Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.2. Spain Gastric Ulcers Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.3. Spain Gastric Ulcers Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Gastric Ulcers Market

• 21.1. Eastern Europe Gastric Ulcers Market Overview
• 21.2. Eastern Europe Gastric Ulcers Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.3. Eastern Europe Gastric Ulcers Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.4. Eastern Europe Gastric Ulcers Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Gastric Ulcers Market

• 22.1. Russia Gastric Ulcers Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.2. Russia Gastric Ulcers Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.3. Russia Gastric Ulcers Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Gastric Ulcers Market

• 23.1. North America Gastric Ulcers Market Overview
• 23.2. North America Gastric Ulcers Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.3. North America Gastric Ulcers Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.4. North America Gastric Ulcers Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Gastric Ulcers Market

• 24.1. USA Gastric Ulcers Market Overview
• 24.2. USA Gastric Ulcers Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.3. USA Gastric Ulcers Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.4. USA Gastric Ulcers Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Gastric Ulcers Market

• 25.1. Canada Gastric Ulcers Market Overview
• 25.2. Canada Gastric Ulcers Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.3. Canada Gastric Ulcers Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.4. Canada Gastric Ulcers Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Gastric Ulcers Market

• 26.1. South America Gastric Ulcers Market Overview
• 26.2. South America Gastric Ulcers Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.3. South America Gastric Ulcers Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.4. South America Gastric Ulcers Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Gastric Ulcers Market

• 27.1. Brazil Gastric Ulcers Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.2. Brazil Gastric Ulcers Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.3. Brazil Gastric Ulcers Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Gastric Ulcers Market

• 28.1. Middle East Gastric Ulcers Market Overview
• 28.2. Middle East Gastric Ulcers Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.3. Middle East Gastric Ulcers Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.4. Middle East Gastric Ulcers Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Gastric Ulcers Market

• 29.1. Africa Gastric Ulcers Market Overview
• 29.2. Africa Gastric Ulcers Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.3. Africa Gastric Ulcers Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.4. Africa Gastric Ulcers Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Gastric Ulcers Market Competitive Landscape And Company Profiles

• 30.1. Gastric Ulcers Market Competitive Landscape
• 30.2. Gastric Ulcers Market Company Profiles
  • 30.2.1. Pfizer Inc.
    • 30.2.1.1. Overview
    • 30.2.1.2. Products and Services
    • 30.2.1.3. Strategy
    • 30.2.1.4. Financial Performance
  • 30.2.2. Merck & Co Inc.
    • 30.2.2.1. Overview
    • 30.2.2.2. Products and Services
    • 30.2.2.3. Strategy
    • 30.2.2.4. Financial Performance
  • 30.2.3. AbbVie Inc.
    • 30.2.3.1. Overview
    • 30.2.3.2. Products and Services
    • 30.2.3.3. Strategy
    • 30.2.3.4. Financial Performance
  • 30.2.4. Sanofi S.A.
    • 30.2.4.1. Overview
    • 30.2.4.2. Products and Services
    • 30.2.4.3. Strategy
    • 30.2.4.4. Financial Performance
  • 30.2.5. AstraZeneca plc
    • 30.2.5.1. Overview
    • 30.2.5.2. Products and Services
    • 30.2.5.3. Strategy
    • 30.2.5.4. Financial Performance

31. Gastric Ulcers Market Other Major And Innovative Companies

• 31.1. Abbott Laboratories
• 31.2. Novartis AG
• 31.3. GlaxoSmithKline plc
• 31.4. Takeda Pharmaceutical Co. Ltd
• 31.5. Amgen Inc.
• 31.6. Boehringer Ingelheim
• 31.7. Viatris Inc.
• 31.8. Daiichi Sankyo Company Limited
• 31.9. Eisai Co. Ltd
• 31.10. Cadila Pharmaceuticals
• 31.11. Dr. Reddy's Laboratories Ltd.
• 31.12. Hikma Pharmaceuticals PLC
• 31.13. Lupin Limited
• 31.14. Yuhan Corporation
• 31.15. Daewoong Pharmaceutical Co. Ltd

32. Global Gastric Ulcers Market Competitive Benchmarking

33. Global Gastric Ulcers Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Gastric Ulcers Market

35. Gastric Ulcers Market Future Outlook and Potential Analysis

• 35.1 Gastric Ulcers Market In 2028 - Countries Offering Most New Opportunities
• 35.2 Gastric Ulcers Market In 2028 - Segments Offering Most New Opportunities
• 35.3 Gastric Ulcers Market In 2028 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer